Medidata, a Dassault Systèmes brand and leader of clinical trial solutions to the life sciences industry, is kicking off NEXT New York 2024, its premier life sciences conference. Uniting more than ...

As the demand for advanced technology surges, DuPont will be featuring its extensive portfolio of innovative products and solutions at Electronica 2024, the world's premier trade fair for electronics, ...

AstraZeneca (AZN) and Daiichi Sankyo have submitted a new Biologics License Application for accelerated approval in the US for datopotamab deruxtecan for the treatment of adult patients with locally ...

Alteogen Inc. said that it has entered into an exclusive license agreement with Daiichi Sankyo (DSKYF.PK). As per the terms of the ...

LONDON — AstraZeneca said Tuesday it has had to resubmit a closely watched medicine for U.S. approval in a different form of ...

A subcutaneous version of Daiichi Sankyo’s AstraZeneca-partnered blockbuster antibody-drug conjugate (ADC) Enhertu could be ...

Merck (NYSE: MRK) recently reported its Q3 results, with revenues and earnings exceeding the street estimates.

Link Parks Inc. Dep. Pfd. (Rep. 1/1000th 5.25% Cum. Redeem. Pfd. Series X) 0.00% Link Parks Inc. Dep. Pfd. (Rep. 1/1000th Share 4.875% Pfd. Series Z) 0.00% Link Parks ...

Just over a decade after being acquired by Daiichi Sankyo, US biotech Plexxikon will be shuttered at the end of March, with its R&D projects transferred to other areas of the Japanese group. It's ...

Berkshire Hathaway Inc. Cl A-1.76% $1.01T Berkshire Hathaway Inc. Cl B-1.82% $1.01T VF Corp. 3.87% $8.11B Under Armour Inc. Cl C 23.14% $3.64B Under Armour Inc. Cl A 27.09% $3.64B ...

Shares in Esperion Therapeutics lost more than half of their value after it disclosed a dispute with Daiichi Sankyo on a $300 million milestone payment relating to cholesterol drug Nexletol.

8316.T Sumitomo Mitsui Financial Group, Inc.